Randomized trials show no evidence of non-specific vaccine effects

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted ...
NatureOpinion

‘It keeps me awake at night’: machine-learning pioneer on AI’s threat to humanity

Yoshua Bengio talks about his efforts to identify — and address — the risks posed by AI.

Adam Grant on lessons from the pandemic, datum versus data, and how abstract numbers can lead to very real human outcomes

In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...
Novartis

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...